Skip to main content

Three-dimensional structures of Plasmodium falciparum spermidine synthase with bound inhibitors suggest new strategies for drug design

Author(s): Sprenger, Janina; Svensson, Bo; Hålander, Jenny; Carey, Jannette; Persson, Lo; et al

To refer to this page use:
Abstract: The enzymes of the polyamine-biosynthesis pathway have been proposed to be promising drug targets in the treatment of malaria. Spermidine synthase (SpdS; putrescine aminopropyltransferase) catalyzes the transfer of the aminopropyl moiety from decarboxylated S-adenosylmethionine to putrescine, leading to the formation of spermidine and 5′-methylthioadenosine (MTA). In this work, X-ray crystallography was used to examine ligand complexes of SpdS from the malaria parasite Plasmodium falciparum (PfSpdS). Five crystal structures were determined of PfSpdS in complex with MTA and the substrate putrescine, with MTA and spermidine, which was obtained as a result of the enzymatic reaction taking place within the crystals, with dcAdoMet and the inhibitor 4-methylaniline, with MTA and 4-aminomethylaniline, and with a compound predicted in earlier in silico screening to bind to the active site of the enzyme, benzimidazol-(2-yl)pentan-1-amine (BIPA). In contrast to the other inhibitors tested, the complex with BIPA was obtained without any ligand bound to the dcAdoMet-binding site of the enzyme. The complexes with the aniline compounds and BIPA revealed a new mode of ligand binding to PfSpdS. The observed binding mode of the ligands, and the interplay between the two substrate-binding sites and the flexible gatekeeper loop, can be used in the design of new approaches in the search for new inhibitors of SpdS. © 2015, IUCR. All rights reserved.
Publication Date: 1-Mar-2015
Electronic Publication Date: 26-Feb-2015
Citation: Sprenger, Janina, Svensson, Bo, Hålander, Jenny, Carey, Jannette, Persson, Lo, Al-Karadaghi, Salam. (2015). Three-dimensional structures of Plasmodium falciparum spermidine synthase with bound inhibitors suggest new strategies for drug design. Acta Crystallographica Section D Biological Crystallography, 71 (3), 484 - 493. doi:10.1107/S1399004714027011.
DOI: doi:10.1107/S1399004714027011
EISSN: 1399-0047
Pages: 71.1:484 - 493
Type of Material: Journal Article
Journal/Proceeding Title: Acta Crystallographica Section D Biological Crystallography
Version: Final published version. This is an open access article.
Notes: Acta Crystallographica Section D: Biological Crystallography. Volume 71, 1 March 2015, Pages 484-493.

Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.